文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

呼吸机相关性肺炎患者中肺部曲霉病的预测

Prediction of pulmonary aspergillosis in patients with ventilator-associated pneumonia.
PubMed 文献 · Ann Intensive Care · 2023-11-07
一句话结论在VAP患者中,基于免疫抑制和入院淋巴细胞计数<0.8 G/L构建的PiPa评分(0–2分)有助于预测ICU获得性肺部曲霉病,但需外部验证。

在法国西部布列塔尼4个ICU中,1636例机械通气患者中215例发生VAP,其中39例(18%)发生IPA。以免疫抑制(1分)和入院淋巴细胞计数<0.8 G/L(1分)构建PiPa评分,在学习队列和验证队列中验证。高PiPa评分(2分)的敏感性为50%/52%、特异性为90%/87%;中等PiPa评分(1分)的敏感性为94%/91%、特异性为44%/46%;AUC分别为0.783和0.770。作者认为该评分有良好预测价值,可能有助于预测VAP患者的IPA,但需外部验证。

要点

  • 在VAP患者中,高PiPa评分(2分:免疫抑制+入院淋巴细胞<0.8 G/L)特异性90%/87%,敏感性50%/52%,可帮助识别IPA高危患者。
  • 中等PiPa评分(1分)敏感性94%/91%、特异性44%/46%,适用于排除IPA。
  • 免疫抑制(包括血液肿瘤、免疫调节治疗、实体器官移植、中性粒细胞<0.5 G/L、泼尼松等效剂量≥1 mg/kg/d)是IPA的独立预测因素(p=0.001,1分)。
  • 入院淋巴细胞计数<0.8 G/L是IPA的独立预测因素(p=0.019,1分)。
  • PiPa评分预测IPA的AUC在学习队列为0.783,验证队列为0.770。

适用人群与场景

  • 在法国西部布列塔尼4个ICU中发生VAP的机械通气患者。

诊断标准与关键阈值

  • PiPa评分:免疫抑制(包括血液肿瘤、免疫调节治疗、实体器官移植、中性粒细胞<0.5 G/L、泼尼松等效剂量≥1 mg/kg/d)1分;入院淋巴细胞计数<0.8 G/L 1分;总分0–2分。
  • 高PiPa评分定义为2分;中等PiPa评分定义为1分。

研究设计与关键结果

  • 研究类型:在4个ICU中开展,评分在学习队列中构建并在验证队列中验证。
  • 共1636例机械通气患者,215例发生VAP,其中39例(18%)发生IPA(4例可能,35例很可能/推测)。
  • 39例IPA中31例通过支气管肺泡灌洗样本培养阳性确诊。
  • 免疫抑制是IPA的独立预测因素(p=0.001;评分1分)。
  • 入院淋巴细胞计数<0.8 G/L是IPA的独立预测因素(p=0.019;评分1分)。
  • 高PiPa评分(2分)在学习队列敏感性50%、特异性90%,在验证队列敏感性52%、特异性87%。
  • 中等PiPa评分(1分)在学习队列敏感性94%、特异性44%,在验证队列敏感性91%、特异性46%。
  • PiPa评分预测IPA的AUC在学习队列为0.783,验证队列为0.770。

证据类型、等级与局限

  • 证据类型:在4个ICU中开展的队列研究,评分在学习队列中构建并在验证队列中验证。
  • 局限:原文报告需外部验证以确认初步发现。

对床旁实践的改变

  • 作者认为,该临床评分有良好预测价值,可能有助于预测VAP患者的IPA。
  • 作者指出,需外部验证以确认初步发现。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Predictors of ICU-acquired pulmonary aspergillosis (IPA) are not well-established in critically ill patients with ventilator-associated pneumonia (VAP), making IPA commonly misdiagnosed and anti-fungal therapy delayed. We aimed to develop a clinical score for prediction of IPA among patients with VAP.

METHODS: Mechanically ventilated patients who developed VAP in 4 ICUs in Bretagne, Western France, were included. The score was constructed in a learning cohort, based on predictors of IPA in logistic regression model, and validated in a validation cohort.

RESULTS: Among 1636 mechanically ventilated patients, 215 developed VAP but only 39 developed IPA (4 possible and 35 probable/putative) (18%). Most cases (31/39) were documented through a positive broncho-alveolar sample culture. Independent predictors of IPA were immunodepression (including onco-hematological disorder, immunomodulatory treatment, solid organ transplant, neutropenia < 0.5G/L and high-dose steroids ≥ 1 mg/kg/day of prednisolone equivalent) (p = 0.001; score = 1 point) and lymphocyte count at admission < 0.8 G/L (p = 0.019; score = 1 point). Operational values of the predictive score in the learning/validation cohort were 50%/52% sensitivity and 90%/87% specificity, respectively, for high PiPa score (score = 2) and 94%/91% sensitivity and 44%/46% specificity, respectively, for moderate PiPa score (score = 1). Finally, the AUC for the prediction of IPA was 0.783 in the learning cohort and 0.770 in the validation cohort.

CONCLUSIONS: We evaluated a clinical score with good predictive value which may help to predict IPA in patient with VAP. External validation will be needed to confirm our preliminary findings.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Massart N, Plainfosse E, Benameur Y, et al. Prediction of pulmonary aspergillosis in patients with ventilator-associated pneumonia. Ann Intensive Care. 2023. PMID: 37935890. doi:10.1186/s13613-023-01199-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。